Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022433

Expand all

BRILINTA (TICAGRELOR)
60MG Marketing Status: Prescription

Active Ingredient: TICAGRELOR
Proprietary Name: BRILINTA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 60MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N022433
Product Number: 002
Approval Date: Sep 3, 2015
Applicant Holder Full Name: ASTRAZENECA PHARMACEUTICALS LP
Marketing Status:  Prescription
Patent and Exclusivity Information

BRILINTA (TICAGRELOR)
90MG Marketing Status: Prescription

Active Ingredient: TICAGRELOR
Proprietary Name: BRILINTA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 90MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N022433
Product Number: 001
Approval Date: Jul 20, 2011
Applicant Holder Full Name: ASTRAZENECA PHARMACEUTICALS LP
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English